Saturday, September 24, 2022

Transition to newer clot-busting drug improves patient outcomes, lowers cost in treating ischemic stroke

A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.

from Latest Science News -- ScienceDaily https://ift.tt/d1BleFx
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Study finds untreated sleep apnea doubles Parkinson’s risk

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lowe...